News zum Sektor Mischkonzerne aus Polen

 

OKLAHOMA CITY--(BUSINESS WIRE)--Wheeler Bio, an innovative contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies, announced the closing of an oversubscribed Series A-1 financing round. The $35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises. Wheeler Bio is a high science, high touch CDMO built upon its foundational scientific platform, Modular CMC. Along with supporting the ongoing success of clients, this financing will broaden Wheeler's capabilities and pave the way for future growth – including planning the build-out of a 52,000 square foot large scale biologics manufacturing facility adjacent to a biomanufacturing workforce training center (BioTC) at Convergence in the Oklahoma City Innovation District. “This investment will fuel Wheeler's ongoing efforts to expand...

Polish travel platform eSky will acquire Thomas Cook from Chinese group Fosun for a total of £30m (€35.6m). The acquisition provides eSky access to Thomas Cook's portfolio including over 500 airlines, enhancing its competitive edge in the tra...